Kathy Turner V - 10 Nov 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Senior Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Kathy V. Turner
Issuer symbol
IDXX
Transactions as of
10 Nov 2022
Net transactions value
-$3,295,376
Form type
4
Filing time
14 Nov 2022, 16:00:11 UTC
Previous filing
22 Feb 2022
Next filing
05 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $1,098,851 +5,310 +77% $206.94 12,233 10 Nov 2022 Direct F1
transaction IDXX Common Stock Sale $1,088,596 -2,655 -22% $410.02 9,578 10 Nov 2022 Direct F2
transaction IDXX Common Stock Sale $10,153 -25 -0.26% $406.11 9,553 10 Nov 2022 Direct F3
transaction IDXX Common Stock Sale $1,065,710 -2,630 -28% $405.21 6,923 10 Nov 2022 Direct F4
transaction IDXX Common Stock Options Exercise $1,527,153 +8,567 +124% $178.26 15,490 11 Nov 2022 Direct
transaction IDXX Common Stock Sale $1,134,734 -2,567 -17% $442.05 12,293 11 Nov 2022 Direct F5
transaction IDXX Common Stock Sale $1,314,000 -3,000 -23% $438.00 9,923 11 Nov 2022 Direct
transaction IDXX Common Stock Sale $1,308,187 -3,000 -30% $436.06 6,923 11 Nov 2022 Direct F6
holding IDXX Common Stock 100 10 Nov 2022 by spouse F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -5,310 -63% 3,056 10 Nov 2022 Common Stock 5,310 $206.94 Direct F8, F10
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -8,567 -84% 1,581 11 Nov 2022 Common Stock 8,567 $178.26 Direct F9, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 37 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2022, June 30, 2022 and, September 30, 2022.
F2 Represents the weighted average price of the shares sold ranging from a low of $410.00 to a high of $410.35 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F3 Represents the weighted average price of the shares sold ranging from a low of $406.10 to a high of $406.115 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F4 Represents the weighted average price of the shares sold ranging from a low of $405.00 to a high of $405.87 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F5 Represents the weighted average price of the shares sold ranging from a low of $442.00 to a high of $442.0125 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F6 Represents the weighted average price of the shares sold ranging from a low of $435.00 to a high of $435.21 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F7 The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein.
F8 Grant of option to buy shares of Issuer common stock that vest in five annual installments beginning February 14, 2020.
F9 Grant of option to buy shares of Issuer common stock that vest in five annual installments beginning February 14, 2019.
F10 Not applicable.